VEGFR2/CD309 antibody (pTyr1175)
Quick Overview for VEGFR2/CD309 antibody (pTyr1175) (ABIN1870314)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pTyr1175
-
Characteristics
- Expected molecular weight of target: 1356 kDa
-
Purification
- Affinity purification
-
Immunogen
- A phospho specific peptide corresponding to residues surrounding Y1175 of human KDR
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:1000, IHC 1:50-1:100, IF 1:100-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR
-
Molecular Weight
- 230 kDa
-
Gene ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-